We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




MRI-Guided Focused Ultrasound System Burns Breast Cancer Tumors without Surgery

By MedImaging International staff writers
Posted on 11 Oct 2023
Image: Patient being treated with the MUSE breast cancer ablation system (Photo courtesy of University of Utah Health)
Image: Patient being treated with the MUSE breast cancer ablation system (Photo courtesy of University of Utah Health)

In a significant breakthrough in the field of non-invasive treatments for breast cancer, scientists have developed a technology capable of eliminating tumors without the need for surgical intervention, all within an outpatient setting.

The MUSE breast cancer treatment system developed by researchers from the Huntsman Cancer Institute at University of Utah Health (Salt Lake City, UT, USA) employs a two-step, non-surgical approach for locating and ablating, or removing, breast tumors. Initially, magnetic resonance imaging (MRI) is utilized to identify and pinpoint the tumors. Once the tumors are located, focused ultrasound technology is used to heat and subsequently destroy the cancerous cells. The entire treatment, which allows the patient to stay awake, takes about 90 minutes and is completed within a few hours.

Designed with patient comfort in mind, the MUSE system incorporates a special table for use during the MRI. The specialized device focuses ultrasound waves into a specific area of the tumor. These waves heat the cancerous tissue in intervals of 30 seconds, and are directed to cover the whole tumor. Currently in its phase 1 clinical trials, the first patient in the U.S. was treated using the MUSE system in a pioneering clinic trial in February 2023. The research team anticipates that it will take at least five years to advance through phase 3 clinical trials before MUSE becomes commercially available as a surgery-free option for treating breast cancer.

“The purpose of the current study is to see how well patients tolerate the ablation, basically how much pain they have during the procedure,” said Cindy Matsen, MD, breast surgeon at Huntsman Cancer Institute, who is the principal investigator for this clinical trial. “We’ll also be looking at the tissue after surgery to see how effective the ablation was. Only 50% is being ablated at this point to make sure we can still do tests that may be needed on the tumor afterwards. In the future, we hope this ablation will be effective enough to replace surgery for some women.”

Related Links:
University of Utah Health 

Mammo DR Retrofit Solution
DR Retrofit Mammography
Ultrasonic Pocket Doppler
SD1
Medical Radiographic X-Ray Machine
TR30N HF
X-ray Diagnostic System
FDX Visionary-A

Channels

Nuclear Medicine

view channel
Image: The new tracer, 64Cu-NOTA-EV-F(ab′)2​, targets nectin-4, a protein strongly linked to tumor growth in both TNBC and UBC cancer types. (Wenpeng Huang et al., DOI: 10.2967/jnumed.125.270132)

PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers

Triple-negative breast cancer (TNBC) and urothelial bladder carcinoma (UBC) are aggressive cancers often diagnosed at advanced stages, leaving limited time for effective treatment decisions.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.